Dopamine was shown to induce mydriasis by excitation of alpha-adrenergic receptors at the dilator pupillae muscle. Pupilla diameter may thus serve as an indirect measure of peripheral pharmacokinetics of L-DOPA and dopamine. The aim of this study is to evaluate the effect of L-DOPA dosage on pupillometric parameters in Parkinson's disease (PD) patients. Sixteen PD patients and 14 healthy control subjects (CS) were studied. The statistical analysis revealed significant differences between CS and PD patients for the mean maximum and minimum pupil diameters (p = 0.017, p = 0.028, respectively), with higher values found in PD. Moreover, a significant dose-response relationship was found between the maximum pupil diameter and both the morning L-DOPA dose (R 2 = 0.78) and the total daily L-DOPA dose (R 2 = 0.93). A sigmoid-shaped curve best describes the dose-response relationship, with a ceiling effect at about 400 mg L-DOPA daily dose. In conclusion, measuring pupillometric parameters represents a sensitive tool for non-invasive evaluation of the peripheral effect of L-DOPA, especially with daily doses below 400 mg L-DOPA.

Department of Neurology and Centre of Clinical Neuroscience 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

Department of Pharmacology 1st Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

J Neural Transm (Vienna). 2018 Sep;125(9):1401. doi: 10.1007/s00702-018-1884-2. PubMed

Zobrazit více v PubMed

Cent Nerv Syst Agents Med Chem. 2011 Dec 1;11(4):305-20 PubMed

Curr Neuropharmacol. 2017 May 10;:null PubMed

Int J Neurosci. 2012 Jan;122(1):26-34 PubMed

Int J Psychophysiol. 1998 Aug;29(3):303-10 PubMed

World J Cardiol. 2015 Apr 26;7(4):204-14 PubMed

Clin Auton Res. 1991 Mar;1(1):55-8 PubMed

Parkinsonism Relat Disord. 2011 Feb;17(2):77-83 PubMed

J Clin Pharm Ther. 2011 Aug;36(4):513-7 PubMed

Br Med J. 1971 May 22;2(5759):438-9 PubMed

Int J Neurosci. 2011 Jan;121(1):37-43 PubMed

Eur J Clin Pharmacol. 2006 Jan;62(1):75-6; author reply 77-8 PubMed

Pharmacol Rev. 1980 Dec;32(4):337-62 PubMed

Physiol Res. 2007;56(1):129-36 PubMed

Invest Ophthalmol. 1976 May;15(5):371-80 PubMed

Nat Rev Dis Primers. 2017 Mar 23;3:17013 PubMed

Int J Psychophysiol. 2009 Aug;73(2):143-9 PubMed

Am J Ther. 1998 Jan;5(1):37-43 PubMed

Int J Psychophysiol. 2009 May;72(2):97-101 PubMed

Longitudinal analysis of pupillometry according to type of pharmacotherapy in Parkinson's disease patients